Home > Income Statement > DIVIS LABORATORIES

DIVIS LABORATORIES
Revenue

    Back to Income Statement
DIVIS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best 1M Momentum Large Cap Stocks
COMMUNITY POLL
for DIVIS LABORATORIES
Please provide your vote to see the results

DIVIS LABORATORIES Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹9,360 Cr₹7,845 Cr₹7,767 Cr₹8,960 Cr₹6,969 Cr

What is the latest Revenue of DIVIS LABORATORIES ?

The latest Revenue ratio of DIVIS LABORATORIES is ₹9,360 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹9,360 Cr
Mar2024₹7,845 Cr
Mar2023₹7,767 Cr
Mar2022₹8,960 Cr
Mar2021₹6,969 Cr

How is Revenue of DIVIS LABORATORIES Trending?

Years Revenue % Change
Mar2025 ₹9,360 Cr
19.31
Mar2024 ₹7,845 Cr
1.00
Mar2023 ₹7,767 Cr
-13.31
Mar2022 ₹8,960 Cr
28.56
Mar2021 ₹6,969 Cr -

Compare Revenue of peers of DIVIS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DIVIS LABORATORIES ₹176,638.5 Cr 3.4% 12.6% 8.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹436,859.0 Cr 4.2% 5.3% 1.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,718.0 Cr 2.2% 4.1% 28% Stock Analytics
CIPLA ₹107,722.0 Cr 2% 11.5% -13.4% Stock Analytics
DR REDDYS LABORATORIES ₹106,081.0 Cr -6.2% 5.1% 9.5% Stock Analytics
MANKIND PHARMA ₹95,803.0 Cr 2.2% 16% -11.6% Stock Analytics


DIVIS LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
DIVIS LABORATORIES

3.4%

12.6%

8.3%

SENSEX

-0.4%

7.1%

-4%


You may also like the below Video Courses